In This Section      
 

2011- Increase in JHM IRB Review Fees

December 9, 2011

TO:
JHU SOM Department Directors, Administrators and Principal Investigators

FROM:
Daniel Ford, M.D., M.P.H.
Vice Dean for Clinical Investigation

SUBJECT:
Increase in JHM IRB Review Fees

As you know, the JHM IRB bills for review of commercially funded studies with financial support in excess of $10,000.  Unlike commercial IRBs, the JHM IRB charges for the initial review and annual continuing reviews and not for changes in research. The fees collected from reviewing commercial studies help fund the IRB.  We do not charge for review of NIH and unsponsored studies. 

To help offset the rising costs of clinical research and fund staffing for the increased number of studies under JHM IRB review, the IRB review fees will be increased as of March 1, 2012. Any study submitted and/or approved on or after the March 1, 2012 date will be subject to the fee increases. After reviewing fee structures at similar institutions conducting human subjects research, we have determined the new fees to be in line or below the national average. The fees are as follow:

Type of Review

Initial Review

Continuing Review

Convened

$2500

$1250

Expedited

$2000

$1000

Exempt

$100

N/A

To ensure each department is treated fairly and to increase overall efficiency, we continue to require each department to specify a non-sponsored account for billing IRB review fees.  All IRB review fees for principal investigators in that department will be billed against that account until it is determined that a study specific Internal Order number has been assigned to the reviewed study.